共 2 条
- [1] The EGALITY study: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasis [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (04) : 928 - 938
- [2] Kavanaugh A, 2017, ARTHRITIS RHEUMATOL, V69